G01N 2333/811
Serine protease inhibitors
Official title: Serine protease (E.C. 3.4.21) inhibitors
G01N2333/811 (Serine protease inhibitors) appears on 317 US grants and 312 published applications in this corpus.
Search patents in G01N- Granted patents
- 317
- Published applications
- 312
- Assignees
- 247
- Inventors
- 819
- Latest grant
- 26 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 1 | 0 |
| 1979 | 1 | 0 |
| 1980 | 3 | 0 |
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 4 | 0 |
| 1984 | 3 | 0 |
| 1985 | 3 | 0 |
| 1986 | 1 | 0 |
| 1987 | 3 | 0 |
| 1988 | 2 | 0 |
| 1989 | 3 | 0 |
| 1990 | 2 | 0 |
| 1991 | 2 | 0 |
| 1992 | 3 | 0 |
| 1993 | 4 | 0 |
| 1994 | 5 | 0 |
| 1995 | 8 | 0 |
| 1996 | 9 | 0 |
| 1997 | 26 | 0 |
| 1998 | 39 | 0 |
| 1999 | 15 | 0 |
| 2000 | 13 | 0 |
| 2001 | 13 | 1 |
| 2002 | 8 | 8 |
| 2003 | 9 | 17 |
| 2004 | 6 | 16 |
| 2005 | 5 | 6 |
| 2006 | 6 | 9 |
| 2007 | 3 | 14 |
| 2008 | 7 | 9 |
| 2009 | 2 | 14 |
| 2010 | 7 | 14 |
| 2011 | 6 | 10 |
| 2012 | 8 | 12 |
| 2013 | 6 | 16 |
| 2014 | 6 | 13 |
| 2015 | 8 | 23 |
| 2016 | 8 | 20 |
| 2017 | 4 | 8 |
| 2018 | 15 | 13 |
| 2019 | 7 | 15 |
| 2020 | 4 | 11 |
| 2021 | 10 | 5 |
| 2022 | 3 | 16 |
| 2023 | 5 | 10 |
| 2024 | 4 | 12 |
| 2025 | 4 | 13 |
| 2026 | 2 | 7 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Aptamer based system to quantify anti-thrombin III in blood26 May 2026US 12,637,679 B2University of Florida Research Foundation, Inc.
- Cancer test method5 May 2026US 12,618,842 B2National Institute of Advanced Industrial Science and Technology
- System for insurance underwriting and post policy issuance action30 Dec 2025US 12,512,191 B2
- Method of screening for a chronic kidney disease or glomerulopathy method of monitoring a response to treatment of a chronic kidney disease or glomerulopathy in a subject and a method of treatment of a chronic kidney disease or glomerulopathy21 Oct 2025US 12,449,426 B2Instytut Biochemii I Biofizyki Pan
- Anti-serine protease inhibitor kazal (SPIK) antibodies, immunoconjugates, and methods of use5 Aug 2025US 12,377,162 B2ImCare Biotech, LLC
- Methods of treating endometriosis1 Oct 2026US 2026/0298926 A1Cedars-Sinai Medical Center
- Glycoprotein biomarkers for ovarian cancer diagnosis1 Oct 2026US 2026/0298932 A1Proseek Bio Pty Ltd.
- Use of kit for diagnosing or assisting in diagnosis of spn1 Oct 2026US 2026/0298937 A1Junmo (Beijing) Biotherapeutics Co., Ltd.
- Depletion of high-abundance plasma proteins using in situ growth of metal-organic frameworks (mofs) for proteomic analysis and biomarker discovery10 Sep 2026US 2026/0266814 A1
- Inter-alpha inhibitor proteins and methods of use thereof14 May 2026US 2026/0130975 A1ProThera Biologics, Inc.
Most cited
By later US patents
- Methods for identifying nucleic acid ligands856US 5,270,163 AUniversity Research Corporation · 1993
- Nucleic acid ligands561US 5,475,096 AUniversity Research Corporation · 1995
- Polybifunctional reagent having a polymeric backbone and photoreactive moieties and bioactive groups478US 6,121,027 ASurModics, Inc. · 2000
- Systematic evolution of ligands by exponential enrichment: Solution SELEX337US 5,567,588 AUniversity Research Corporation · 1996
- Systematic evolution of ligands by exponential enrichment: chimeric selex281US 5,637,459 ANeXstar Pharmaceuticals, Inc. · 1997